SCHEMBL28889159

SCHEMBL28889159

COc1cccc(C(C(N)=O)c2cc(C(F)(F)F)ccn2)c1F

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 1/20 0.41
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
ADRB2 P07550 1/20 0.37
AURKA O14965 1/20 0.37
CTSA P10619 4/20 0.37
RORB Q92753 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
BRAF P15056 1/20 0.36
NPC1 O15118 1/20 0.36
USP2 O75604 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28994016 0.91 ADRB2 (0.40) HCRTR1HCRTR2ADRB2CTSARORB
SCHEMBL28889307 0.85 ADRB2 (0.38) ADRB2AURKAKDM4EALDH1A1L3MBTL1
SCHEMBL28889381 0.82 ADRB2 (0.39) GPBAR1ADRB2ALDH1A1L3MBTL1
SCHEMBL28889339 0.80 ADRB2 (0.42) ADRB2AURKACTSAALDH1A1L3MBTL1
SCHEMBL28959168 0.80 HDAC4 (0.44) ADRB2AURKA
SCHEMBL28889367 0.79 ADRB2 (0.41) ADRB2AURKAALDH1A1L3MBTL1
SCHEMBL28889298 0.79 ADRB2 (0.39) ADRB2AURKAKMT2AALDH1A1L3MBTL1
SCHEMBL29893770 0.79 HDAC4 (0.43) ADRB2AURKAUSP2KMT2A
SCHEMBL28889170 0.79 HDAC4 (0.43) ADRB2AURKAUSP2KMT2A
SCHEMBL24110333 0.79 TACR1 (0.45) ADRB2AURKAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022222911-A1 PYRIMIDONE COMPOUND AND USE THEREOF 武汉人福创新药物研发中心有限公司 2022-10-27 WO disclosed
CN-115215862-A Pyrimidone compounds and uses thereof 武汉人福创新药物研发中心有限公司 2022-10-21 CN disclosed